Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. Before moving to Paris, he was head of the Transplant Program at the University-Hospital of Nantes, France. He also undertook post-doctoral work at the Haematology Department, Imperial College, Hammersmith Hospital, London, UK
Professor Mohty’s translational research activity is focused on the pathophysiology of graft-vs-host disease and the immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as IMiDs and hypomethylating agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of multiple myeloma.
Professor Mohty has published more than 210 peer-reviewed articles in the field of stem cell transplantation, leukaemia and myeloma, in different haematology and immunology journals.
QUALITYFORLIFE CIC is a (Not for Profit) company registered in England with company number 12037798
Copyright © 2019 WhatsApp: 0044 77 900 77 999 Contact email: firstname.lastname@example.org